RGA(US:RGA)2025-10-31 16:49Financial Performance - Total revenues for Q3 2025 reached $6,204 million, a 9.7% increase from $5,651 million in Q3 2024[10] - Net premiums for Q3 2025 were $4,280 million, down 2.5% from $4,391 million in Q3 2024[10] - Net investment income increased to $1,475 million in Q3 2025, compared to $1,188 million in Q3 2024, reflecting a 24.2% growth[10] - Net income for Q3 2025 was $255 million, up 61.6% from $158 million in Q3 2024[10] - Basic earnings per share for Q3 2025 were $3.85, compared to $2.37 in Q3 2024, representing a 62.5% increase[10] - Comprehensive income for Q3 2025 was $1,055 million, compared to $1,450 million in Q3 2024, reflecting a decrease of 27.2%[12] Assets and Liabilities - Total assets as of September 30, 2025, amounted to $152,003 million, up from $118,675 million at the end of 2024, a growth of 28.0%[8] - Total liabilities increased to $138,935 million as of September 30, 2025, compared to $107,769 million at the end of 2024, a rise of 28.9%[8] - The company reported total equity of $13,068 million as of September 30, 2025, up from $10,906 million at the end of 2024, a growth of 19.8%[8] Cash Flow and Investments - Total cash provided by operating activities for the nine months ended September 30, 2025, was $3,239 million, a decrease from $7,770 million in 2024[16] - Net cash used in investing activities for the nine months ended September 30, 2025, was $8,824 million, compared to $8,383 million in 2024[16] - The balance of cash and cash equivalents at the end of the period on September 30, 2025, was $4,625 million, down from $5,195 million at the end of September 2024[16] Shareholder Returns - Dividends to shareholders increased to $0.93 per share in Q3 2025 from $0.89 per share in Q3 2024[15] - The company repurchased 406,337 shares of common stock during the nine months ended September 30, 2025, with $425 million remaining under the share repurchase authorization[26] Future Policy Benefits - Future policy benefits rose to $66,389 million as of September 30, 2025, compared to $53,368 million at the end of 2024, an increase of 24.5%[8] - The liability for future policy benefits for the Traditional business increased by $183 million in Q3 2025, compared to a $39 million increase in Q3 2024, primarily due to updated mortality and lapse assumptions[33] Investment Performance - The company reported a total investment income of $4,280 million for the nine months ended September 30, 2025, compared to $3,359 million for the same period in 2024, reflecting a growth of 27.4%[81] - The total fixed maturity securities as of September 30, 2025, amounted to $45,788 million, with unrealized losses of $6,512 million[80] Segment Performance - The U.S. and Latin America segment generated revenues of $2,190 million, while the Europe, Middle East, and Africa segment contributed $1,070 million[164] - The segment revenues for U.S. and Latin America amounted to $6,701 million, while Europe, Middle East, and Africa contributed $1,985 million[166] Regulatory and Compliance - The company does not expect any material adverse effects from pending legal, regulatory, and governmental matters on its financial condition[151] - The company is required to maintain a consolidated stockholders' equity above $2.0 billion to avoid triggering certain provisions in the facility agreement[177] Accounting and Standards - The company anticipates adopting new accounting standards related to income taxes and disaggregation of income statement expenses by December 31, 2025, and December 31, 2027, respectively[180]